SCA practice case · Video consultation

“I’m desperate for the loo all the time and sometimes don’t make it — I just want a tablet to stop it”

Video consultation Adult patient Straightforward Long-term conditions & cancerGender, reproductive & sexual health

The candidate brief

This is what you would read in the 3-minute window before the patient connects. Read it once, note two or three hypotheses and one thing you must not miss, then stop.

Patient
Diane Foster · 55 years · female
Setting
Video consultation — urinary urgency, frequency and urge incontinence.
Past history
  • Nil recorded
Medication
  • Nil recorded
Allergies
NKDA
Recent notes
No previous consultations for bladder symptoms.
Reason for contact
Video consultation booked online: “bladder problem, embarrassing”.

Practise this case

The full case is in the Hot Seat with the Gold plan. You get a 12-minute timer, a role-player script with facts released only when asked, examiner checkpoints by the three RCGP domains, a model consultation and the guidance behind it.

What this case tests

Show the learning points (spoiler: read after you have practised)
Urinary urgency, frequency, nocturia and urge incontinence suggest OVERACTIVE BLADDER (OAB), but before treating, EXCLUDE other causes and RED FLAGS: urinary infection (urine dip/culture), diabetes/polyuria (glucose/HbA1c), neurological disease, and medications (diuretics, caffeine) — and critically check for unexplained VISIBLE HAEMATURIA (NICE NG12: aged 45 and over without UTI, or persisting/recurring after UTI treatment → suspected cancer pathway urology referral), remembering that persistent urinary urgency or frequency is also an NG12 ovarian cancer symptom (CA125 at 40+; urgent ultrasound at 50–59 if 31 IU/mL or more) — so a pill must not be the first move. Characterise the incontinence type, as management differs: URGE (sudden urgency then leak — OAB), STRESS (leak on cough/exertion — pelvic floor/structural), or MIXED, clarified by a focused history (± face-to-face examination) and a bladder diary. NICE NG123 recommends CONSERVATIVE measures FIRST: a bladder diary (at least 3 days), lifestyle changes (reduce caffeine and alcohol, sensible fluid intake — neither too much nor too little, weight loss if relevant), and BLADDER TRAINING (scheduled voiding with gradually increased intervals for a minimum of 6 weeks), adding pelvic floor exercises if there is a stress/mixed component — these are effective first-line measures, not a delay tactic. Only if conservative measures are insufficient should MEDICATION follow — an antimuscarinic (oxybutynin/tolterodine/solifenacin, counselling anticholinergic side-effects and caution/avoidance of oxybutynin in older/frail patients) or mirabegron (a beta-3 agonist, NICE TA290; BP measured before and during treatment, contraindicated at 180/110 or more, MHRA October 2015), reviewed 4 weeks after starting, with vaginal oestrogen for postmenopausal vaginal atrophy — with referral to continence/urology services if refractory (Botox, neuromodulation). Acknowledge the significant social, sleep and quality-of-life impact and the embarrassment, take it seriously, and frame conservative management positively. The hidden agenda is the wish for a quick "pill to stop it" amid embarrassment and impact; validate the distress, exclude red flags (especially haematuria and the ovarian route → NICE NG12), and explain conservative-first with medication as a next step — not first line.

The guidance behind it

Similar SCA cases

Browse all 359 cases by experience group →

gpreasoning.uk is not affiliated with or endorsed by the RCGP. Our cases are original teaching material written for practice; none is an exam recall. For anything official about the SCA, check the RCGP SCA pages.